Orgenesis reports record revenue as it looks to develop scalable processing solutions for cell therapies 03-Sep-2019 By Melissa Fassbender Orgenesis is developing a ‘distributed’ processing solution – backed by its point-of-care cell therapy platform and CDMO business – to provide approved cell therapies to patients at a fraction of today’s costs, says company executive.